• Most Popular
  • Most Shared

Fresenius may conclude removab talks early 2008

Wed Oct 31, 2007 5:45am EDT

Stocks

   

FRANKFURT, Oct 31 (Reuters) - Fresenius SE (FREG.DE) is looking to conclude talks with potential marketing partners for experimental cancer drug removab early next year, Chief Executive Ulf Schneider said on Wednesday.

Fresenius had said it would look for a partner to develop and market the drug in North America and Japan, while it will focus itself on Europe.

In July, Fresenius reported more positive data from a Phase II/III trial of its removab antibody in treating patients with malignant ascites, an accumulation of fluid in the abdominal cavity.

Fresenius is the parent of Fresenius Medical Care (FMC) (FMEG.DE), the world's largest dialysis care company.



More from Reuters

A Greenpeace activist dressed as one of the "Four Horsemen of the Apocalypse" rides outside the parliament building during a brief protest in Copenhagen December 13, 2009. REUTERS/Christian Charisius

The face of climate protest

Protesters around the globe called for an end to global warming as climate talks in Copenhagen entered their sixth day.  Video 

    Climate conference
    President Barack Obama (R) meets with financial services industry leaders in the Roosevelt Room of the White House in Washington December 14, 2009. REUTERS/Larry Downing

    Obama takes "fat cats" to task

    Backed by Americans outraged by multi-billion dollar bailouts, President Obama met with a dozen of Wall Street's top bankers in a bid to crack down on the so-called "fat cats" largely held responsible for the financial crisis.  Full Article 

    Executive Compensation
    Lockheed Martin Chief Executive Robert Stevens answers a question during the Reuters Aerospace and Defense Summit in Washington December 14, 2009. REUTERS/Molly Riley

    Lockheed eyes deals

    The future demands of cybersecurity make that sector one of many the aerospace giant sees as an acquisition target in the coming year.  Full Article 

    Aerospace and Defense Summit